Abstract Title:

Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation.

Abstract Source:

Biol Pharm Bull. 2010;33(4):641-6. PMID: 20410599

Abstract Author(s):

Li-Hong Qiu, Xian-Ji Xie, Bi-Qi Zhang

Article Affiliation:

Department of Cardiology, The First Affiliated Hospital, College of Medicine, Zhejiang University.


Astragaloside IV, the major active component extracted from Astragalus membranaceus, exerts multipotent activities under pathophysiological conditions. Hyperhomocysteinemia, an independent risk factor for cardiovascular disease, induces oxidative stress leading to endothelial dysfunction. We investigated the effect of astragaloside IV on acute phase endothelial dysfunction induced by homocysteine. In a concentration-dependent manner, endothelial dysfunction was induced by homocysteine. In organ bath experiment using rat aortic rings, treatment with astragaloside IV resulted in an improvement of the impaired endothelium-dependent vasorelaxation by homocysteine as reflected by the higher maximal vasorelaxation to acetylcholine. However, the presence of N(omega)-nitro-L-arginine methyl ester hydrochloride could abolish the protective effect of astragaloside IV on homocysteine-induced vasomotor dysfunction. In human umbilical vein endothelial cells culture experiment, exposure to astragaloside IV significantly ameliorated the homocysteine-induced inactivation of nitric oxide-nitric oxide synthase signal pathway via reducing oxygen species and increasing the activity of superoxide dismutase. Additionally, pretreatment with superoxide dismutase showed a similar effect to astragaloside IV on attenuation of the homocysteine-induced endothelial dysfunction. These data support the view that astragaloside IV might be advantageous in the treatment of endothelial dysfunction induced by disturbed nitric oxide-nitric oxide synthase pathway due to oxidative stress in hyperhomocysteinemia.

Study Type : Animal Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.